Status:
RECRUITING
Sacral Neuromodulation as Treatment for Fecal Incontinence
Lead Sponsor:
McMaster University
Conditions:
Fecal Incontinence
Eligibility:
All Genders
6-80 years
Phase:
NA
Brief Summary
The objective of this study is to investigate if low level laser therapy will do more good than harm for patients with severe refractory fecal incontinence. It is a proof of concept study without a pl...
Detailed Description
The therapy consists of a 3 week treatment with a total of 8 sessions of low level laser therapy. Effects will be assessed using symptoms and quality of life questionnaires and physiological assessmen...
Eligibility Criteria
Inclusion
- Patients with fecal incontinence
Exclusion
- Pregnant patients
- Known malignancies in the area of treatment
- Active bleeding in area of treatment
- Active deep vein thrombosis
- When tatoos are present at area of treatment
- Patients that are light sensitive
- Patients who take steroids.
Key Trial Info
Start Date :
September 8 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03825575
Start Date
September 8 2019
End Date
February 1 2027
Last Update
April 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McMaster University
Hamilton, Ontario, Canada, L8N3Z5